MedEquities Realty Trust Inc. (NYSE:MRT)‘s stock had its “equal weight” rating reiterated by analysts at Capital One Financial Corporation in a research note issued on Sunday. Capital One Financial Corporation also issued estimates for MedEquities Realty Trust’s Q3 2017 earnings at $0.29 EPS, Q4 2017 earnings at $0.31 EPS, FY2017 earnings at $1.12 EPS, Q1 2018 earnings at $0.30 EPS, Q2 2018 earnings at $0.32 EPS, Q3 2018 earnings at $0.32 EPS, Q4 2018 earnings at $0.32 EPS, FY2018 earnings at $1.26 EPS, Q1 2019 earnings at $0.30 EPS, Q2 2019 earnings at $0.32 EPS, Q3 2019 earnings at $0.32 EPS and FY2019 earnings at $1.28 EPS.

Several other brokerages have also issued reports on MRT. Zacks Investment Research upgraded MedEquities Realty Trust from a “sell” rating to a “hold” rating in a research note on Wednesday, July 19th. KeyCorp restated a “buy” rating and set a $13.00 price target on shares of MedEquities Realty Trust in a research note on Tuesday, September 26th. Finally, Cantor Fitzgerald began coverage on MedEquities Realty Trust in a research note on Thursday, August 31st. They issued an “overweight” rating and a $14.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, two have given a hold rating and four have given a buy rating to the stock. MedEquities Realty Trust presently has an average rating of “Hold” and a consensus target price of $13.00.

MedEquities Realty Trust (NYSE:MRT) opened at 11.57 on Friday. MedEquities Realty Trust has a 12 month low of $10.28 and a 12 month high of $13.06. The firm has a market cap of $367.41 million and a price-to-earnings ratio of 35.17. The stock has a 50 day moving average price of $11.67 and a 200 day moving average price of $11.91.

TRADEMARK VIOLATION WARNING: This article was originally published by American Banking News and is the sole property of of American Banking News. If you are reading this article on another website, it was stolen and republished in violation of United States & international copyright law. The legal version of this article can be read at https://www.americanbankingnews.com/2017/10/25/medequities-realty-trusts-mrt-equal-weight-rating-reaffirmed-at-capital-one-financial-corporation.html.

Several hedge funds have recently added to or reduced their stakes in MRT. UBS Group AG grew its stake in shares of MedEquities Realty Trust by 190.0% in the 1st quarter. UBS Group AG now owns 13,504 shares of the financial services provider’s stock valued at $151,000 after purchasing an additional 8,847 shares during the period. Eqis Capital Management Inc. bought a new stake in shares of MedEquities Realty Trust in the 2nd quarter valued at approximately $153,000. Raymond James Financial Services Advisors Inc. bought a new stake in shares of MedEquities Realty Trust in the 2nd quarter valued at approximately $154,000. Acadian Asset Management LLC bought a new stake in shares of MedEquities Realty Trust in the 2nd quarter valued at approximately $175,000. Finally, Alliancebernstein L.P. bought a new stake in shares of MedEquities Realty Trust in the 2nd quarter valued at approximately $175,000. Institutional investors own 93.17% of the company’s stock.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.

Analyst Recommendations for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust Inc. and related companies with MarketBeat.com's FREE daily email newsletter.